2.1. Study Design
This double-blind, randomized clinical trial was conducted at Ali-Asghar Hospital in Shiraz, Iran, from December 2021 to March 2022. Seventy-six COVID-19 patients admitted to this hospital were enrolled. Randomization was done using a table of random numbers.